Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone

Rodolfo D Vicetti Miguel1, Robert L Hendricks, Alfredo J Aguirre

  • 1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.

Insights

Medroxyprogesterone acetate (MPA) impairs immune responses to herpes simplex virus type 1 (HSV-1) mucosal infections by hindering T cell expansion and memory development. This effect is linked to reduced dendritic cell activation and is site-dependent.

Area of Science:

  • Immunology
  • Virology
  • Endocrinology

Background:

  • Exogenous sex steroids, like medroxyprogesterone acetate (MPA), are known to affect cell-mediated immunity.
  • The precise mechanisms by which MPA influences immune responses, particularly in the context of viral infections, remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of MPA administration on T cell responses and immunological memory following herpes simplex virus type 1 (HSV-1) mucosal infection.
  • To elucidate the role of dendritic cells (DCs) and costimulatory molecules in MPA-mediated immunomodulation.

Main Methods:

  • Mice were treated with MPA prior to HSV-1 corneal infection.
  • Analysis of viral-specific T cell expansion, memory T cell populations, and DC costimulatory molecule expression (CD40, CD70, CD80) in draining lymph nodes.
  • Ex vivo coculture experiments with DCs and T cells.
  • Comparison of mucosal versus systemic infection models.

Main Results:

  • MPA treatment prior to HSV-1 mucosal infection impaired the expansion of viral-specific effector and memory precursor T cells.
  • Reduced numbers of viral-specific memory T cells were observed in latently infected mice.
  • MPA dampened the expression of CD40, CD70, and CD80 on DCs, impairing T cell proliferation.
  • Recombinant soluble CD154 (CD40L) administration restored T cell expansion.
  • Immunomodulatory effects were dependent on the infection site; systemic infection showed normal T cell expansion.

Conclusions:

  • MPA administration before mucosal viral infection impairs DC activation and subsequent virus-specific T cell expansion.
  • MPA interferes with the development of robust virus-specific immunological memory following mucosal infection.
  • The findings highlight the critical role of DCs and costimulatory pathways in MPA's immunomodulatory effects and emphasize the site-specific nature of these impacts.